UBS AM
COV

UBS AM’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

UBS AM’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,547,242
Closed -$158M – 2692
2014
Q4 		$158M Sell
1,547,242
-1,487
-0.1% -$143K 0.15% 157
2014
Q3 		$134M Buy
1,548,729
+29,464
+2% +$2.61M 0.13% 171
2014
Q2 		$137M Sell
1,519,265
-93,486
-6% -$6.99M 0.14% 170
2014
Q1 		$119M Sell
1,612,751
-1,136,819
-41% -$79.3M 0.13% 181
2013
Q4 		$187M Sell
2,749,570
-66,369
-2% -$4.32M 0.21% 119
2013
Q3 		$172M Sell
2,815,939
-309,652
-10% -$18.9M 0.21% 123
2013
Q2 		$174M Buy
+3,125,591
New +$181M 0.22% 115

UBS AM's COV Position: Q1 2015 in Review

UBS AM sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 1,547,242 shares — an estimated $158M sold.

UBS AM first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $187M in Q4 2013. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • UBS AM reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • UBS AM sold 1,547,242 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $158M.
  • UBS AM first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
  • UBS AM's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $187M in Q4 2013.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on UBS AM's 13F filing for Q1 2015, filed 4 May 2015.